Hysteroscopy Procedures Market Report 2025

The hysteroscopy procedures market size has grown strongly in recent years. It will grow from $4.06 billion in 2024 to $4.33 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to collaboration with gynecologists, diagnostic accuracy improvement, evolving training and education, growth in outpatient procedures, minimally invasive surgery trend.

The hysteroscopy procedures market size is expected to see strong growth in the next few years. It will grow to $5.8 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to continued research and innovation, increasing awareness campaigns, enhanced diagnostic accuracy, ongoing training programs, outpatient procedure growth, rising preference for minimally invasive surgery. Major trends in the forecast period include increasing demand for outpatient procedures, advancements in imaging technologies, integration of robotics, focus on fertility treatments, and expansion of diagnostic scope.

The anticipated rise in the prevalence of gynecological problems is poised to drive the growth of the hysteroscopy procedure market. Gynecological disorders, encompassing conditions such as uterine fibroids, menstrual disorders, and polycystic ovarian syndrome, disrupt the normal functioning of the female reproductive system. Hysteroscopy procedures play a crucial role in addressing and preventing an increased occurrence of gynecological ailments by diagnosing and treating issues leading to abnormal uterine bleeding, excessive menstrual bleeding, irregular spotting, and postmenopausal bleeding. Notably, a January 2023 article from the National Center for Biotechnology Information highlighted that over 70% of women develop uterine fibroids by the onset of menopause, and clinically noticeable uterine fibroids affect 25% of women in their fertile age. Additionally, a March 2023 article from the World Health Organization reported that endometriosis impacts nearly 10% (190 million) of reproductive-age women and girls globally. Consequently, the surging prevalence of gynecological problems is fueling the expansion of the hysteroscopy procedure market.

The rising demand for minimally invasive procedures is expected to drive the growth of the hysteroscopy procedures market in the future. Minimally invasive procedures involve medical techniques and surgical interventions characterized by small incisions, specialized instruments, and advanced imaging technology used for diagnosis, treatment, or surgical interventions within the body. This growing preference for minimally invasive options significantly contributes to the expansion of hysteroscopy procedures, driven by factors such as patient preference, enhanced outcomes, technological advancements, and cost-effectiveness, making these procedures more appealing to both patients and healthcare providers. For instance, a report from The Aesthetic Society, a U.S.-based organization focused on plastic surgery and cosmetic medicine, revealed that Americans spent over $11.8 billion on aesthetic procedures in total, representing a 2% increase from the previous year. Thus, the increasing demand for minimally invasive procedures is propelling the growth of the hysteroscopy procedures market.

Leading companies in the hysteroscopy procedures market are concentrating on creating innovative solutions, such as hysteroscopic tissue removal systems, to simplify and enhance the minimally invasive nature of these procedures. A hysteroscopic tissue removal system is a minimally invasive medical device designed for the resection or removal of abnormal tissues within the uterus, utilizing hysteroscopy for real-time visualization and precise treatment. For example, in July 2023, GenWorks Health Private Limited, an India-based equipment and technology solutions firm, introduced a mechanical hysteroscopic tissue removal system. This device facilitates the minimally invasive extraction of intrauterine tissues during hysteroscopic procedures. It employs a straightforward mechanical method, allowing the hysteroscope to be inserted into the uterus, where soft tissue shavers simultaneously cut and aspirate abnormal tissues, such as endometrial fibroids and polyps. Its design enables direct visualization of the intrauterine cavity, ensuring accurate targeting of abnormalities while allowing for tissue collection for pathological analysis. By reducing the dependence on energy discharge and minimizing fluid usage, this system enhances safety and efficiency, leading to shorter procedure times and improved patient outcomes. With a streamlined process that requires fewer steps and only a single insertion, it serves as a valuable tool in gynecological practice.

Major players in the hysteroscopy procedures market are concentrating on introducing innovative products, such as the Hystero-V single-use hysteroscope, to capitalize on the advantages of single-use technology. The Hystero-V, developed by UroViu, offers several benefits for both physicians and patients, including convenience, safety, cost-effectiveness, and portability. In June 2022, UroViu Corporation launched the Hystero-V single-use hysteroscope, positioning it as a significant advancement in single-use hysteroscopy technology. This device is poised to capture a considerable share of the growing global hysteroscope market.

In January 2024, Stille AB, a medical technology company based in Sweden, acquired Fehling Instruments for an undisclosed amount. This acquisition is intended to broaden Stille AB's product portfolio and strengthen its position in the surgical instruments market by incorporating Fehling's innovative solutions and expertise. Fehling Instruments, located in Germany, specializes in developing and manufacturing precision instruments and medical devices specifically for surgical applications.

Major companies operating in the hysteroscopy procedures market include Hologic Inc., CooperSurgical Inc., Stryker Corp., Karl Storz SE & Co. KG, Medtronic plc, Johnson & Johnson Services Inc., Olympus Corporation, B. Braun SE, Richard Wolf GmbH, Erbe Elektromedizin GmbH, Boston Scientific Corporation, MedGyn Products Inc., LiNA Medical ApS, LUMINELLE, Meditrina Inc., Maxer Endoscopy GmbH, Smith & Nephew plc, Cook Medical LLC, Fujifilm Holdings Corporation, ConMed Corporation, Silex Medical LLC, EndoChoice Holdings Inc., Endo Optiks Inc., Hysteroscopy Centers of America LLC.

North America was the largest region in the hysteroscopy procedure market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hysteroscopy procedure market report during the forecast period. The regions covered in the hysteroscopy procedures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hysteroscopy procedures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A hysteroscopy is a diagnostic technique that allows a surgeon to examine the interior of the uterus. It involves the use of a hysteroscope to identify symptoms or problems such as heavy periods, abnormal vaginal bleeding, postmenopausal bleeding, pelvic pain, recurrent miscarriages, or difficulties in conception.

The primary types of products used in hysteroscopy procedures include flexible hysteroscopes, forceps, rigid hysteroscopes, and scissors. Flexible hysteroscopy is considered a secure, efficient, and reliable method for investigating abnormal uterine bleeding. These instruments find applications in various procedures such as hysteroscopy, endometrial ablation, myomectomy, polypectomy, among others, and are utilized by different end-users such as hospitals, clinics, ambulatory surgery centers, and more.

The hysteroscopy procedure market research report is one of a series of new reports that provides hysteroscopy procedure market statistics, including hysteroscopy procedure industry global market size, regional shares, competitors with a hysteroscopy procedure market share, detailed hysteroscopy procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the hysteroscopy procedure industry. This hysteroscopy procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hysteroscopy procedure market consists of revenues earned by entities by providing diagnostic and operative hysteroscopy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hysteroscopy procedures market consists of sales of hysteroscopes, hysterosheaths, and hysteroscopic tissue removal systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.